Domov › Nadváha › Florida

Klinické štúdie Nadváha v štáte Florida

55 štúdií pre Nadváha hľadá účastníkov v zariadeniach v štáte Florida.

Mestá v štáte Florida

Oficiálny text štúdie (anglicky)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Innovative Research of West Florida /ID# 281963, Clearwater
Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
Altus Clinical Research - Lake Worth - South Congress Avenue /ID# 281979, Lake Worth
a 8 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07752979

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Orlando Health, Inc., Orlando

Prebieha nábor

Vek 21 až 65 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07090005

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Kailera Clinical Site, Orlando

Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov

Vek 18 až 85 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07793929

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Northeast Research Institute, Fleming Island
Jacksonville Ctr Clin Res, Jacksonville
Florida Institute for Clinical Research, LLC, Orlando
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Encore Medical Research LLC, Hollywood
Jacksonville Ctr for Clin Res, Jacksonville
Encore Medical Research of Weston, Weston

Prebieha náborFáza 3

Vek 8 až 18 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07253285

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

DM Clinical Research, Bradenton

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07823608

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

AMR Clinical - Miami, Doral
AMR Clinical - Fort Myers, Fort Myers
AGA Clinical Trials, Hialeah
a 6 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Clinical Neuroscience Solutions, Orlando

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Brain Matters Research, Delray Beach
Northeast Research Institute, Fleming Island
Miguel Rebollar PA, Hialeah
a 5 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07720271

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Clinical Pharmacology of Miami, Miami

Prebieha náborFáza 1

Vek 18 až 65 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Encore Medical Research LLC, Hollywood
NextPhase Research, Hollywood
Jacksonville Ctr Clin Res, Jacksonville
a 7 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Excel Medical Clinical Trials, Boca Raton
Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
New Age Medical Research Corporation, Miami
a 5 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Nature Coast Clinical Research, Crystal River
West Coast Eye Institute, Lecanto
South Broward Research, Miramar
a 3 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Jacksonville
Research Site, Jacksonville

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07776509

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Research Associates of South Florida - Miami - Southwest 8th Street, Miami
Gastro Health Research - Miami, Miami
Orlando Health, Orlando
a 3 ďalších

Prebieha náborFáza 3

Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

William A. Shands Hospital at the University of Florida, Gainesville
Florida Hospital- Center for Pediatric Research, Orlando
Nemours Children's Health, Orlando
a 1 ďalších

Prebieha náborFáza 3

Vek 6 až 17 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Research Associates of South Florida - Miami - Southwest 8th Street, Miami
Gastro Health Research - Miami, Miami
Orlando Health, Orlando
a 3 ďalších

Prebieha náborFáza 3

Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937086

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

Clinical Pharmacology of Miami, Miami

Prebieha náborFáza 1

Vek 18 až 70 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07803744

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Arrow Clinical Trials, Daytona Beach
Care Access - Delray Beach, Delray Beach
Fleming Island Center for Clinical Research, Fleming Island
a 7 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

JEM Research Institute, Atlantis
AMR Clinical, Doral
Northeast Research Institute (NERI), Fleming Island
a 4 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Coral Gables
Research Site, Fleming Island
Research Site, Fort Lauderdale
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Flourish Research - Miami, LLC, Miami
PharmaDev Clinical Research Institute, LLC, Miami
Emerald Coast Neurology - Airport Boulevard, Pensacola

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Excel Medical Clinical Trials, Boca Raton
Velocity Clinical Research - New Smyrna Beach, Edgewater
Alliance for Multispecialty Research - Fort Myers, Fort Myers
a 20 ďalších

Prebieha náborFáza 3

Vek 45 až 99 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

JEM Research Institute, Atlantis
BioMed Research & Medical Center, Miami
Adult Medicine of Lake County, Inc., Mt. Dora
a 3 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Westside Center for Clinical Research, Jacksonville
Care Access - St. Petersburg, St. Petersburg
Conquest Research, Winter Park

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

New Horizon Research Center, Miami
Indago Research & Health Center, Inc, Miami Lakes
Suncoast Clinical Research, Inc., New Port Richey
a 2 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Boca Raton
AURORA-1 Clinical Site, Daytona Beach
AURORA-1 Clinical Site, Jacksonville
a 6 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Boca Raton
AURORA-2 Clinical Site, Daytona Beach
AURORA-2 Clinical Site, Jacksonville
a 6 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Tampa Bay Medical Research, Inc., Clearwater
Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
Progressive Medical Research, Port Orange
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Renstar Medical Research, Ocala
Oviedo Medical Research, Oviedo

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06897475

Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households

University of Central Florida, Orlando

Prebieha nábor

Vek 5 až 11 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07464015

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

PharmaDev Clinical Research Institute LLC, Miami
Essence MD Research, Naples
Renstar Medical Research, Ocala

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Clearwater
ACCOMPLISH-2 Research Site, Fort Myers
ACCOMPLISH-2 Research Site, Jacksonville
a 5 ďalších

Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov

Vek 18 až 79 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

ERG Holding Company, LLC / Evolution Research Group, LLC, Delray Beach
ERG Holding Company, LLC / Evolution Research Group, LLC, Fort Myers
Jedidiah Clinical Research, Tampa

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07770841

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

DM Clinical, Bradenton
Essence MD Research, Naples
Palm Beach Research Center, West Palm Beach

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

New Horizon Research Center, Miami
Indago Research & Health Center, Inc, Miami Lakes
Suncoast Clinical Research, Inc., New Port Richey
a 2 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Precision Clinical Research, Sunrise

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

NeoClinical Research, Hialeah
Skin Care Research, Hollywood
Encore Medical Research, Hollywood
a 2 ďalších

Prebieha náborFáza 4

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Bradenton
Kailera Clinical Site, Hollywood
Kailera Clinical Site, Jupiter
a 6 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Jacksonville Center for Clinical Research, Jacksonville
Clinical Neuroscience Solutions - Jacksonville, Jacksonville
South Florida Wellness and Clinical Research Institute, Margate
a 8 ďalších

Prebieha náborFáza 3

Vek 18 až 99 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07684235

Z ClinicalTrials.gov, dáta načítané 4. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.